UTILIZATION OF ELECTRONIC RECORD LINKED GENOTYPE DATA TO EVALUATE THE PATHOGENICITY OF SUSPECTED FAMILIAL CARDIOMYOPATHY DNA VARIANTS  by Yoneda, Zachary et al.
Heart Failure and Cardiomyopathies
A934
JACC March 17, 2015
Volume 65, Issue 10S
utIlIzAtIon of electronIc record lInked genotyPe dAtA to evAluAte the 
PAthogenIcIty of susPected fAmIlIAl cArdIomyoPAthy dnA vArIAnts
Poster Contributions
Poster Hall B1
Sunday, March 15, 2015, 9:45 a.m.-10:30 a.m.
Session Title: World of Cardiomyopathies
Abstract Category: 14.  Heart Failure and Cardiomyopathies: Clinical
Presentation Number: 1184-210
Authors: Zachary Yoneda, Quinn Wells, Jason Becker, Vanderbilt University Medical Center, Nashville, TN, USA
Background:  The evolution of high throughput sequencing technologies has facilitated the rapid expansion of genetic testing in individuals 
with suspected heritable forms of cardiomyopathy. It is challenging to determine the pathogenicity of rare DNA variants in the absence of 
large kindreds that allow determination of variant and disease trait cosegregation.
methods:  During clinical genetic testing of patients with suspected familial cardiomyopathies we uncovered rare DNA variants in RBM20 
(c.2662G>A, D888N), ANKRD1 (c.827C>T, A276V), and DSC2 (c.304G>A, E102K). The ANKRD1 and DSC2 variants have published 
clinical and functional data suggesting they were pathogenic variants in DCM or ARVC, respectively. We screened for carriers of these 
three DNA variants in a population of 32,339 subjects with electronic medial records (EMR) linked genotype data.
results: We identified 195 carriers of RBM20 c. 2662G>A (MAF 0.006), 172 carriers of ANKRD1 c.827 C>T (MAF 0.005) and 83 carriers of 
DSC2 c.304G>A (MAF 0.002). Review of past medical history, family history, and echocardiography data determined that less than 3% of 
variant carriers met criteria for cardiomyopathy despite a median age of ≥ 59 for all three variants (Table 1).
conclusion:  The utilization of EMR linked genotype data is an effective method to explore the pathogenicity of rare DNA variants. Analysis 
of RBM20 c.2662G>A, Ankrd1 c.827C>T and DSC2 c.304G>A suggest these DNA variants are unlikely causes of autosomal dominant 
cardiomyopathies.
Characteristics of Cardiomyopathy in Variant Carriers
Variant RBM20 c.2662G>A (%) ANKRD1 c.827C>T (%) DSC2 c.304G>A (%)
Total Number of Individuals with Variant 
Identified 195 (100) 172 (100) 83 (100)
Median Age (years) 59 61 64
Number of Individuals with echocardiograms 
or cMRI 54 (28) 53 (31) 21 (25)
Cases Meeting Definition of Cardiomyopathy 
(DCM or ARVC) 4 (2.1) 2 (1.2) 2 (2.4)
